277 related articles for article (PubMed ID: 22432707)
1. Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus.
Fernandes S; Proença D; Cantante C; Silva FA; Leandro C; Lourenço S; Milheiriço C; de Lencastre H; Cavaco-Silva P; Pimentel M; São-José C
Microb Drug Resist; 2012 Jun; 18(3):333-43. PubMed ID: 22432707
[TBL] [Abstract][Full Text] [Related]
2. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains.
Proença D; Fernandes S; Leandro C; Silva FA; Santos S; Lopes F; Mato R; Cavaco-Silva P; Pimentel M; São-José C
Microb Drug Resist; 2012 Jun; 18(3):322-32. PubMed ID: 22480295
[TBL] [Abstract][Full Text] [Related]
3. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
4. The Auxiliary Role of the Amidase Domain in Cell Wall Binding and Exolytic Activity of Staphylococcal Phage Endolysins.
Son B; Kong M; Ryu S
Viruses; 2018 May; 10(6):. PubMed ID: 29799482
[TBL] [Abstract][Full Text] [Related]
5. A Novel Strategy to Identify Endolysins with Lytic Activity against Methicillin-Resistant
Kim H; Seo J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982851
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.
Linden SB; Zhang H; Heselpoth RD; Shen Y; Schmelcher M; Eichenseher F; Nelson DC
Appl Microbiol Biotechnol; 2015 Jan; 99(2):741-52. PubMed ID: 25038926
[TBL] [Abstract][Full Text] [Related]
7. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
[TBL] [Abstract][Full Text] [Related]
8. EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.
Proença D; Leandro C; Garcia M; Pimentel M; São-José C
Appl Microbiol Biotechnol; 2015 Jun; 99(12):5137-49. PubMed ID: 25728445
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'.
Schmelcher M; Korobova O; Schischkova N; Kiseleva N; Kopylov P; Pryamchuk S; Donovan DM; Abaev I
J Biotechnol; 2012 Dec; 162(2-3):289-98. PubMed ID: 23026556
[TBL] [Abstract][Full Text] [Related]
10. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci.
Donovan DM; Foster-Frey J
FEMS Microbiol Lett; 2008 Oct; 287(1):22-33. PubMed ID: 18673393
[TBL] [Abstract][Full Text] [Related]
11. Characterization of staphylococcal endolysin LysSAP33 possessing untypical domain composition.
Yu JH; Park DW; Lim JA; Park JH
J Microbiol; 2021 Sep; 59(9):840-847. PubMed ID: 34383247
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus Bacteriophage 52 Endolysin Exhibits Anti-Biofilm and Broad Antibacterial Activity Against Gram-Positive Bacteria.
Abdurahman MA; Durukan İ; Dinçer T; Pektaş S; Karataş E; Kiliç AO
Protein J; 2023 Oct; 42(5):596-606. PubMed ID: 37634214
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.
Haddad Kashani H; Schmelcher M; Sabzalipoor H; Seyed Hosseini E; Moniri R
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187396
[No Abstract] [Full Text] [Related]
14. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
[TBL] [Abstract][Full Text] [Related]
15. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk.
Obeso JM; Martínez B; Rodríguez A; García P
Int J Food Microbiol; 2008 Dec; 128(2):212-8. PubMed ID: 18809219
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage φEf11 ORF28 Endolysin, a Multifunctional Lytic Enzyme with Properties Distinct from All Other Identified Enterococcus faecalis Phage Endolysins.
Zhang H; Buttaro BA; Fouts DE; Sanjari S; Evans BS; Stevens RH
Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 30979842
[TBL] [Abstract][Full Text] [Related]
17. Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of staphylococcal phage endolysins.
Gouveia A; Pinto D; Veiga H; Antunes W; Pinho MG; São-José C
Sci Rep; 2022 Jan; 12(1):1245. PubMed ID: 35075218
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Chimeric Endolysin, Lys109 With Enhanced Lytic Activity Against
Son B; Kong M; Lee Y; Ryu S
Front Microbiol; 2020; 11():615887. PubMed ID: 33519773
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
Basit A; Qadir S; Qureshi S; Rehman SU
Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
[TBL] [Abstract][Full Text] [Related]
20. Development of Advanced Chimeric Endolysin to Control Multidrug-Resistant
Lee C; Kim J; Son B; Ryu S
ACS Infect Dis; 2021 Aug; 7(8):2081-2092. PubMed ID: 34047546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
